# EMPIRE-1 (NCT01666808)

> FACBC Outcomes for Post Prostatectomy

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT01666808
- Phase: PHASE2, PHASE3
- Status: COMPLETED
- Sponsor: Emory University
- Conditions: Prostate Cancer
- Interventions: FACBC; Radiation therapy
- Enrollment: 165
- Primary outcome: Failure-free Survival

## Indexed commentary on EMPIRE-1 so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- X threads: 12
- YouTube: 1
- Podcasts: 1

## Order

Standard, $1,250, price fixed at order: https://www.erudio.com/contact?report=empire-1-nct01666808

## Free preview

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT01666808", "email": "<work email>"}; the inbox owner confirms by the emailed link.